English | 简体中文 | 繁體中文 | 한국어
 All Press Releases

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 10:51 HKT
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 09:24 HKT
第14屆「亞洲物流航運及空運會議」圓滿結束
Nov 19, 2024 22:16 HKT
第14届「亚洲物流航运及空运会议」圆满结束
Nov 19, 2024 21:57 HKT
LQR House Inc. Board of Directors Approves Purchase of Up to $1M Bitcoin as Treasury Reserve Asset and Retention of Up to $10M Crypto Payments on CWSpirits.com
Nov 19, 2024 21:30 HKT
14th Asian Logistics, Maritime and Aviation Conference concludes today
Nov 19, 2024 21:27 HKT
GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR(R)
Nov 19, 2024 21:09 HKT
JBM Healthcare Announces FY2025 Interim Results
Nov 19, 2024 20:51 HKT
健倍苗苗公佈二零二五財年中期業績 純利飆升53.4%至95.9百萬港元
Nov 19, 2024 20:39 HKT
健倍苗苗公布二零二五财年中期业绩 纯利飙升53.4%至95.9百万港元
Nov 19, 2024 20:23 HKT
Fourth Paradigm's Platform Business Grew by 50.2% in the First Three Quarters
Nov 19, 2024 20:05 HKT
第四范式前三季度平台业务增长50.2% 超40款AI产品提供强增长动力
Nov 19, 2024 19:56 HKT
第四範式前三季度平臺業務增長50.2% 超40款AI產品提供強增長動力
Nov 19, 2024 19:37 HKT
CleverTap được công nhận là nhà cung cấp ưu việt trong mảng cross-channel marketing trong Báo cáo của Forrester Wave, Quý 4 năm 2024
Nov 19, 2024 19:00 HKT
可持續內生增長 晶科電子處價值窪地
Nov 19, 2024 18:35 HKT
可持续内生增长 晶科电子处价值洼地
Nov 19, 2024 18:19 HKT
Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 17:54 HKT
Everest Medicines Announces NEFECON(R)'s Full Approval in South Korea
Nov 19, 2024 17:37 HKT
雲頂新耀宣佈耐賦康(R)在韓國獲批 商業化進程再創里程碑
Nov 19, 2024 17:28 HKT
云顶新耀宣布耐赋康(R)在韩国获批 商业化进程再创里程碑
Nov 19, 2024 17:10 HKT
<< Previous Next >>
 Releases By Language
All
English
Indonesian
Japanese
Korean
Thai
Trad. Chinese
Simp. Chinese
Vietnamese
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: